McEllin, Brian <br/><br/>
PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.  [electronic resource] 

 -  Cancer research  Jul 2010 
 - 5457-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-4295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--pharmacology<br/>Astrocytes--drug effects<br/>Benzimidazoles--pharmacology<br/>Brain Neoplasms--drug therapy<br/>Cyclin-Dependent Kinase Inhibitor p16--deficiency<br/>DNA Damage<br/>DNA Repair<br/>Dacarbazine--analogs & derivatives<br/>Glioblastoma--drug therapy<br/>Methylnitronitrosoguanidine--pharmacology<br/>Mice<br/>Mice, Transgenic<br/>PTEN Phosphohydrolase--deficiency<br/>Poly(ADP-ribose) Polymerase Inhibitors<br/>Recombination, Genetic<br/>Temozolomide